These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36983610)

  • 1. Safety and Tolerability of Concentrated Intraventricular Nicardipine for Poor-Grade Aneurysmal Subarachnoid Hemorrhage-Related Vasospasm.
    Zahra K; Domingo RA; Turnbull MT; Santos CD; Peacock SH; Jackson DA; Tawk RG; Siegel JL; Freeman WD
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983610
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraventricular nicardipine for aneurysmal subarachnoid hemorrhage related vasospasm: assessment of 90 days outcome.
    Lu N; Jackson D; Luke S; Festic E; Hanel RA; Freeman WD
    Neurocrit Care; 2012 Jun; 16(3):368-75. PubMed ID: 22160865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage.
    Goodson K; Lapointe M; Monroe T; Chalela JA
    Neurocrit Care; 2008; 8(2):247-52. PubMed ID: 17968520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Hyperacute Onset of Vasospasm After Aneurysmal Subarachnoid Hemorrhage and Refractory Vasospasm Treated with Intravenous and Intraventricular Nitric Oxide: A Mini Review.
    Ehlert A; Manthei G; Hesselmann V; Mathias K; Bein B; Pluta R
    World Neurosurg; 2016 Jul; 91():673.e11-8. PubMed ID: 27109628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions.
    Tejada JG; Taylor RA; Ugurel MS; Hayakawa M; Lee SK; Chaloupka JC
    AJNR Am J Neuroradiol; 2007 May; 28(5):844-8. PubMed ID: 17494654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intraventricular administration of nicardipine on mean cerebral blood flow velocity measured by transcranial Doppler in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage.
    Webb A; Kolenda J; Martin K; Wright W; Samuels O
    Neurocrit Care; 2010 Apr; 12(2):159-64. PubMed ID: 20012709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Review of Intrathecal Nicardipine for the Treatment of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
    Hafeez S; Grandhi R
    Neurocrit Care; 2019 Oct; 31(2):399-405. PubMed ID: 30607826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage.
    Hoh BL; Topcuoglu MA; Singhal AB; Pryor JC; Rabinov JD; Rordorf GA; Carter BS; Ogilvy CS
    Neurosurgery; 2004 Oct; 55(4):779-86; discussion 786-9. PubMed ID: 15458586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review.
    Stuart D; Christian R; Uschmann H; Palokas M
    JBI Database System Rev Implement Rep; 2018 Oct; 16(10):2013-2026. PubMed ID: 30335041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article.
    Fountas KN; Tasiou A; Kapsalaki EZ; Paterakis KN; Grigorian AA; Lee GP; Robinson JS
    Neurosurg Focus; 2009 May; 26(5):E22. PubMed ID: 19409001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of intraventricular nicardipine for refractory vasospasm in aneurysmal subarachnoid hemorrhage with improved neurophysiology on intracranial multimodality monitoring: illustrative case.
    Grandhi R; Menacho ST; Ravindra VM; Condie C; Taussky P; Hawryluk GWJ
    J Neurosurg Case Lessons; 2022 May; 3(22):CASE22113. PubMed ID: 35734609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early permanent cerebrospinal fluid diversion in aneurysmal subarachnoid hemorrhage: does a lower rate of nosocomial meningitis outweigh the risk of delayed cerebral vasospasm related morbidity?
    Croci DM; Dalolio M; Aghlmandi S; Taub E; Rychen J; Chiappini A; Zumofen D; Guzman R; Mariani L; Roethlisberger M
    Neurol Res; 2021 Jan; 43(1):40-53. PubMed ID: 33106124
    [No Abstract]   [Full Text] [Related]  

  • 14. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.
    Hänggi D; Etminan N; Macdonald RL; Steiger HJ; Mayer SA; Aldrich F; Diringer MN; Hoh BL; Mocco J; Strange P; Faleck HJ; Miller M
    Neurocrit Care; 2015 Oct; 23(2):274-84. PubMed ID: 25678453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric Oxide-Based Treatment of Poor-Grade Patients After Severe Aneurysmal Subarachnoid Hemorrhage.
    Ehlert A; Starekova J; Manthei G; Ehlert-Gamm A; Flack J; Gessert M; Gerss J; Hesselmann V
    Neurocrit Care; 2020 Jun; 32(3):742-754. PubMed ID: 31418143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage.
    Macdonald RL; Hänggi D; Ko NU; Darsaut TE; Carlson AP; Wong GK; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Ng D; Strange P; Bleck T; Grubb R; Suarez JI
    Neurosurgery; 2020 Dec; 88(1):E13-E26. PubMed ID: 32985652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.
    Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369
    [No Abstract]   [Full Text] [Related]  

  • 18. Age-Dependent Radiographic Vasospasm and Delayed Cerebral Ischemia in Women After Aneurysmal Subarachnoid Hemorrhage.
    Lai PMR; Gormley WB; Patel N; Frerichs KU; Aziz-Sultan MA; Du R
    World Neurosurg; 2019 Oct; 130():e230-e235. PubMed ID: 31203057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage.
    Pegoli M; Mandrekar J; Rabinstein AA; Lanzino G
    J Neurosurg; 2015 Feb; 122(2):414-8. PubMed ID: 25495745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of the Practical Risk Chart for the prediction of delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage.
    Foreman PM; Chua MH; Harrigan MR; Fisher WS; Tubbs RS; Shoja MM; Griessenauer CJ
    J Neurosurg; 2017 May; 126(5):1530-1536. PubMed ID: 27177181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.